Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Florence Abravanel and Jacques Izopet.
Connection Strength

7.337
  1. Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein. J Clin Virol. 2020 09; 130:104528.
    View in: PubMed
    Score: 0.890
  2. Performance of a commercial assay for detecting and quantifying HEV RNA in faeces. J Clin Virol. 2018 12; 109:1-5.
    View in: PubMed
    Score: 0.790
  3. A fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faeces. J Clin Virol. 2018 08; 105:109-111.
    View in: PubMed
    Score: 0.773
  4. Rabbit Hepatitis E Virus Infections in Humans, France. Emerg Infect Dis. 2017 07; 23(7):1191-1193.
    View in: PubMed
    Score: 0.723
  5. Evaluation of two VIDAS ®prototypes for detecting anti-HEV IgG. J Clin Virol. 2017 04; 89:46-50.
    View in: PubMed
    Score: 0.706
  6. Testing individual and pooled saliva samples for sars-cov-2 nucleic acid: a prospective study. Diagn Microbiol Infect Dis. 2021 Nov; 101(3):115478.
    View in: PubMed
    Score: 0.239
  7. Diagnosis options in patients suffering from COVID-19-like symptoms. J Med Virol. 2021 Jul; 93(7):4076-4077.
    View in: PubMed
    Score: 0.235
  8. Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021 01; 82(1):e29-e32.
    View in: PubMed
    Score: 0.226
  9. Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens. J Clin Virol. 2020 08; 129:104541.
    View in: PubMed
    Score: 0.223
  10. Hepatitis E Virus Infections among Patients with Acute Febrile Jaundice in Burkina Faso. Viruses. 2019 06 14; 11(6).
    View in: PubMed
    Score: 0.207
  11. Acute hepatitis E in French patients and neurological manifestations. J Infect. 2018 09; 77(3):220-226.
    View in: PubMed
    Score: 0.194
  12. Diversity of hepatitis E virus genotype 3. Rev Med Virol. 2018 09; 28(5):e1987.
    View in: PubMed
    Score: 0.193
  13. Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort. Antivir Ther. 2018; 23(4):307-314.
    View in: PubMed
    Score: 0.187
  14. Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world. J Hepatol. 2018 03; 68(3):595-597.
    View in: PubMed
    Score: 0.184
  15. Chronic hepatitis E virus infection in a cirrhotic patient: A case report. Medicine (Baltimore). 2017 Sep; 96(39):e7915.
    View in: PubMed
    Score: 0.183
  16. Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response. Biochimie. 2017 Oct; 141:70-79.
    View in: PubMed
    Score: 0.179
  17. Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France. Emerg Infect Dis. 2017 02; 23(2):353-356.
    View in: PubMed
    Score: 0.176
  18. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010 Mar 01; 50(5):e30-3.
    View in: PubMed
    Score: 0.109
  19. Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept. Transplantation. 2021 09 01; 105(9):e94-e95.
    View in: PubMed
    Score: 0.060
  20. Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Am J Transplant. 2022 01; 22(1):322-323.
    View in: PubMed
    Score: 0.060
  21. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N Engl J Med. 2021 08 12; 385(7):661-662.
    View in: PubMed
    Score: 0.060
  22. Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int. 2021 10; 100(4):915-927.
    View in: PubMed
    Score: 0.059
  23. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Ann Intern Med. 2021 09; 174(9):1336-1338.
    View in: PubMed
    Score: 0.059
  24. Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV Diagnosis. J Infect Dis. 2019 07 31; 220(5):811-819.
    View in: PubMed
    Score: 0.052
  25. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses. 2019 07 09; 11(7).
    View in: PubMed
    Score: 0.052
  26. Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection? Transpl Infect Dis. 2019 06; 21(3):e13065.
    View in: PubMed
    Score: 0.051
  27. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transpl Infect Dis. 2019 04; 21(2):e13050.
    View in: PubMed
    Score: 0.050
  28. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 01; 70(1):206-209.
    View in: PubMed
    Score: 0.049
  29. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018 12; 38(12):2178-2189.
    View in: PubMed
    Score: 0.048
  30. Monitoring human enteric viruses in wastewater and relevance to infections encountered in the clinical setting: a one-year experiment in central France, 2014 to 2015. Euro Surveill. 2018 02; 23(7).
    View in: PubMed
    Score: 0.047
  31. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.046
  32. Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein. Gastroenterology. 2018 01; 154(1):211-223.e8.
    View in: PubMed
    Score: 0.046
  33. Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study. J Hepatol. 2017 11; 67(5):925-932.
    View in: PubMed
    Score: 0.045
  34. Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study. Transpl Infect Dis. 2017 Aug; 19(4).
    View in: PubMed
    Score: 0.045
  35. Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma. PLoS One. 2017; 12(4):e0174651.
    View in: PubMed
    Score: 0.044
  36. Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Antiviral Res. 2017 05; 141:150-154.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.